Modifi Biosciences is a biotech company developing an oncology therapeutics platform. It is based on the classes of molecules that exploit tumor-associated DNA repair defects through direct cancer cell DNA modification. The company focuses on creating therapeutics that uniquely target specific acquired cancer cell DNA mutations.